37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Review article: natural history and epidemiology of Helicobacter pylori infection.

      1
      Alimentary pharmacology & therapeutics
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Helicobacter pylori is a common bacterium infecting about half the world's population. It is causally linked with a diverse spectrum of gastrointestinal clinical disorders including peptic ulcer disease, gastric cancer, and gastric MALT lymphoma. The principal reservoir is the human stomach, and transmission probably occurs by person-to-person passage. Prevalence rates are generally much higher in developing countries compared to developed countries, although there are subgroups within many regions with higher H. pylori prevalence than in the general population. The prevalence of H. pylori varies by geographical location, ethnic background, socioeconomic conditions, and age. Recent studies suggest decreasing prevalence in developed countries or those with rapidly improving socioeconomic conditions. Comparative studies of the two fully sequenced H. pylori genomes are providing understanding of its large genetic diversity and bacterial virulence factors. The discovery of the type IV secretion system in H. pylori and its role in translocation of the CagA protein from the bacterial cell into the host epithelial cell provides insight into how host-bacterial interaction may lead to host disease. Cytokine promoter polymorphisms are determinants important in host gastric acid secretion status. Understanding the changing trends in H. pylori epidemiology, details of its transmission pathways, and the bacterial and host determinants leading to gastroduodenal disease remain the challenges in this area. Global epidemiological studies, advances in technology, and medical interventions have converged to help clarify the mechanisms of interaction between this ubiquitous micro-organism and its host that result in its diverse clinical manifestations.

          Related collections

          Author and article information

          Journal
          Aliment Pharmacol Ther
          Alimentary pharmacology & therapeutics
          Wiley
          0269-2813
          0269-2813
          Mar 2002
          : 16 Suppl 1
          Affiliations
          [1 ] GI Section, Veterans Administration Salt Lake City Health Care System, Division of Gastroenterology, University of Utah School of Medicine, Salt Lake City, Utah 84148, USA. mae.go@med.va.gov
          Article
          119
          10.1046/j.1365-2036.2002.0160s1003.x
          11849122
          94b26078-c5fd-4b2a-979d-8d89fe310456
          History

          Comments

          Comment on this article